Privia Health Group (NASDAQ:PRVA) CFO David Mountcastle Sells 5,566 Shares

Privia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle sold 5,566 shares of the business’s stock in a transaction on Thursday, April 2nd. The stock was sold at an average price of $20.85, for a total value of $116,051.10. Following the sale, the chief financial officer owned 214,847 shares of the company’s stock, valued at approximately $4,479,559.95. The trade was a 2.53% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

David Mountcastle also recently made the following trade(s):

• On Monday, March 16th, David Mountcastle sold 6,391 shares of Privia Health Group stock. The stock was sold at an average price of $22.11, for a total value of $141,305.01.
• On Friday, March 13th, David Mountcastle sold 6,565 shares of Privia Health Group stock. The stock was sold at an average price of $21.52, for a total value of $141,278.80.
• On Thursday, March 12th, David Mountcastle sold 6,453 shares of Privia Health Group stock. The stock was sold at an average price of $21.90, for a total value of $141,320.70.
• On Monday, March 9th, David Mountcastle sold 5,829 shares of Privia Health Group stock. The stock was sold at an average price of $22.84, for a total value of $133,134.36.
• On Friday, March 6th, David Mountcastle sold 5,177 shares of Privia Health Group stock. The stock was sold at an average price of $23.15, for a total value of $119,847.55.
• On Thursday, February 26th, David Mountcastle sold 5,361 shares of Privia Health Group stock. The stock was sold at an average price of $25.00, for a total transaction of $134,025.00.
• On Friday, February 27th, David Mountcastle sold 7,697 shares of Privia Health Group stock. The stock was sold at an average price of $25.05, for a total transaction of $192,809.85.

Privia Health Group Price Performance

PRVA opened at $21.59 on Tuesday. The company has a market cap of $2.67 billion, a price-to-earnings ratio of 127.00, a price-to-earnings-growth ratio of 1.32 and a beta of 0.87. The firm has a 50 day simple moving average of $22.09 and a 200 day simple moving average of $23.42. Privia Health Group, Inc. has a fifty-two week low of $18.77 and a fifty-two week high of $26.51.

Privia Health Group (NASDAQ:PRVA) last released its quarterly earnings data on Thursday, February 26th. The company reported $0.25 EPS for the quarter, beating analysts’ consensus estimates of $0.04 by $0.21. The business had revenue of $541.17 million during the quarter, compared to the consensus estimate of $516.61 million. Privia Health Group had a return on equity of 3.06% and a net margin of 1.08%.The firm’s revenue was up 17.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.21 earnings per share. As a group, analysts expect that Privia Health Group, Inc. will post 0.14 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have commented on PRVA shares. Piper Sandler reaffirmed an “overweight” rating and issued a $36.00 target price on shares of Privia Health Group in a research note on Thursday, February 26th. Canaccord Genuity Group upped their target price on shares of Privia Health Group from $34.00 to $35.00 and gave the company a “buy” rating in a research note on Friday, February 27th. Royal Bank Of Canada began coverage on Privia Health Group in a report on Friday, January 9th. They issued an “outperform” rating and a $31.00 price target for the company. Jefferies Financial Group restated a “buy” rating and issued a $32.00 price target on shares of Privia Health Group in a report on Thursday, February 26th. Finally, Truist Financial increased their price target on Privia Health Group from $31.00 to $33.00 and gave the stock a “buy” rating in a report on Monday, March 2nd. Thirteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $31.13.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the company. Bayban bought a new position in shares of Privia Health Group during the fourth quarter worth about $26,000. Hantz Financial Services Inc. grew its holdings in shares of Privia Health Group by 456.2% during the fourth quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company’s stock worth $27,000 after buying an additional 926 shares in the last quarter. Global Retirement Partners LLC grew its holdings in shares of Privia Health Group by 579.8% during the fourth quarter. Global Retirement Partners LLC now owns 1,584 shares of the company’s stock worth $38,000 after buying an additional 1,351 shares in the last quarter. Canada Pension Plan Investment Board grew its holdings in shares of Privia Health Group by 48.0% during the second quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock worth $85,000 after buying an additional 1,200 shares in the last quarter. Finally, Kestra Advisory Services LLC bought a new position in Privia Health Group in the fourth quarter valued at $93,000. 94.48% of the stock is currently owned by institutional investors.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.